Life Science Co. Gets $150M Funding From TPG Sixth Street
Molecular science innovation company Caris Life Sciences said on Monday that it has raised $150 million in funding from TPG Sixth Street Partners that it will use in part to continue...To view the full article, register now.
Already a subscriber? Click here to view full article